| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/10/1991 | US5047511 Method for recovering recombinant proteins |
| 09/10/1991 | US5047510 Method of purification of transforming growth factor-beta |
| 09/10/1991 | US5047509 Abnormally glycosylated variants of a2 macroglobulin |
| 09/10/1991 | US5047506 Method for the purification of factor XIII by affinity chromatography |
| 09/10/1991 | US5047505 High level expression in E. coli of soluble mature HIL-1beta and derivatives with altered biological activity |
| 09/10/1991 | US5047504 Method for purifying granulocyte-macrophage colony stimulating factor |
| 09/10/1991 | US5047503 Prepared by ion exchange and affinity chromatography from human urine; remedy for thrombosis |
| 09/10/1991 | US5047502 Cell Growth Inhibitors |
| 09/10/1991 | US5047397 Linear analogs of atrial natriuretic peptides |
| 09/10/1991 | US5047396 Intravenous pharmaceutical composition and process for preparing the same |
| 09/10/1991 | US5047395 Reduction of oxyradical damage in biomedical applications |
| 09/10/1991 | US5047336 DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides |
| 09/10/1991 | US5047334 To produce proteins consisting of specific dna system |
| 09/10/1991 | US5047333 Method for the preparation of natural human growth hormone in pure form |
| 09/10/1991 | US5047257 Sprout-damaged wheat flour containing barley alpha-amylase inhibitor |
| 09/10/1991 | US5047237 Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine |
| 09/10/1991 | CA2076030A1 Interleukin-4 binding proteins |
| 09/10/1991 | CA2037835A1 Tri-functional antibody-like compounds as a combined diagnostic and therapeutics agent |
| 09/10/1991 | CA2037153A1 Acetic acid derivatives |
| 09/10/1991 | CA1288897C Cosmetic preparations comprising novel elastin derivatives |
| 09/10/1991 | CA1288896C Immunoglobulin conjugates |
| 09/10/1991 | CA1288895C Inducer factor of t-suppressor cells |
| 09/10/1991 | CA1288894C Physiologically active peptides having bronchodilative and hypotensive activity |
| 09/10/1991 | CA1288692C Interferon assay |
| 09/09/1991 | CA2037741A1 Delipidated polysaccharide composition, method for preparing same |
| 09/07/1991 | CA2037499A1 Preparation of a thrombin-binding substance |
| 09/06/1991 | CA2037478A1 Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator |
| 09/06/1991 | CA2031688A1 Ultrafiltration method for purification of a pediococcal bacteriocin |
| 09/05/1991 | WO1991013361A1 Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus |
| 09/05/1991 | WO1991013360A1 NEW HIV p24 PEPTIDES, DIAGNOSTIC ANTIGENS AND DISCRIMINATIVE IMMUNOASSAY METHOD |
| 09/05/1991 | WO1991013175A1 Inhibitors of herpes simplex virus replication |
| 09/05/1991 | WO1991013167A1 Identification and expression of insect steroid receptor dna sequences |
| 09/05/1991 | WO1991013159A2 Regeneration and genetic transformation of sugar beet |
| 09/05/1991 | WO1991013158A1 Protein production in yeast |
| 09/05/1991 | WO1991013155A1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
| 09/05/1991 | WO1991013097A1 Polyaminocarboxylic acid derivatives |
| 09/05/1991 | WO1991013095A1 Hypoxia-induced proteins including an activator of coagulation factor x and methods of preparation and use |
| 09/05/1991 | WO1991013094A1 Inhibitor of proliferation of endothelial cells |
| 09/05/1991 | WO1991013086A1 Endotoxin-induced thrombosis factor which induces procoagulant activity in epithelial cells |
| 09/05/1991 | WO1991013077A1 Calcium channel compositions and methods |
| 09/05/1991 | WO1991012812A1 Inhibitors of catalytic antibodies |
| 09/05/1991 | WO1991012811A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/05/1991 | WO1991012730A2 Recovery of protein, protein isolate and/or starch from cereal grains |
| 09/05/1991 | WO1991012718A1 Enhanced cryopreservation with thermal hysteresis peptide |
| 09/05/1991 | WO1991011525A3 Vaccines |
| 09/05/1991 | WO1991010722A3 Chimeric immunoglobulin for cd4 receptors |
| 09/05/1991 | WO1991009973A3 C. difficile specific oligonucleotides |
| 09/05/1991 | WO1991006866A3 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 09/05/1991 | WO1991006314A3 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 09/05/1991 | DE4005630A1 Monoclonal antibodies against tumour-associated antigens - specifically MAB BW SCLC-1 and MAB BW SCLC-2, used in immune therapy and treatment and diagnosis of tumours |
| 09/05/1991 | CA2074523A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/04/1991 | EP0445099A1 Method for purifying somatotropin monomers |
| 09/04/1991 | EP0444961A1 Her3: A novel EGF receptor homolog |
| 09/04/1991 | EP0444897A1 Novel immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| 09/04/1991 | EP0444664A2 Fusaric acid resistant genes |
| 09/04/1991 | EP0444638A2 Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus |
| 09/04/1991 | EP0444605A2 Angiotensin converting enzyme inhibitor, method for preparing it, composition containing the same and use thereof |
| 09/04/1991 | EP0444560A1 Antibody specific for the tumor necrosis factor receptor |
| 09/04/1991 | EP0444181A1 C-erbb-2 external domain: gp75 |
| 09/04/1991 | EP0444158A1 Conjugated polypeptides and methods for their preparation and use. |
| 09/04/1991 | EP0444157A1 Collagen-polymer conjugates |
| 09/04/1991 | EP0444154A1 Hdl-binding proteins |
| 09/04/1991 | EP0444149A1 High molecular weight human angiogenic factors |
| 09/04/1991 | EP0444129A1 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use |
| 09/04/1991 | EP0444040A1 Complete nucleotidic sequence of the complementary dna of the genomic rna of the potyvirus, genes coding for the potyvirus capside protein and application of said genes to the creation of potyvirus-resistant transgenic plants |
| 09/04/1991 | EP0271542B1 An acellular red blood cell substitute |
| 09/04/1991 | CN1054170A Fertile transgenic corn plants |
| 09/04/1991 | CA2037446A1 Human monoclonal antibodies against rabies viruses, the production and the use thereof |
| 09/03/1991 | WO1991013166A1 Antibody constructs with enhanced binding affinity |
| 09/03/1991 | WO1991013093A1 CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME |
| 09/03/1991 | WO1991013090A1 Improved chimeric toxins |
| 09/03/1991 | WO1991013087A1 Hybrid compound purification |
| 09/03/1991 | WO1991013085A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 09/03/1991 | WO1991012819A1 Improved immunogenic compositions |
| 09/03/1991 | US5045636 Low closure force EMI/RFI shielded door |
| 09/03/1991 | US5045633 Expression of biologically active PDGF analogs in eucaryotic cells |
| 09/03/1991 | US5045631 Polypeptides with cell-spreading activity |
| 09/03/1991 | US5045537 Hydrophilic renin inhibitors, their preparation and use |
| 09/03/1991 | US5045531 Administering amphiphilic polypeptide as wound healing agent |
| 09/03/1991 | US5045469 Novel bacillus thuringiensis isolate denoted B. T. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 09/03/1991 | US5045462 Basic protein called phospholipase A2 isolated from the venom of a snake of the family elapidae and its amino acid sequence |
| 09/03/1991 | US5045461 Method for increasing yield and nodulation by bradyrhizobium |
| 09/03/1991 | US5045460 DNA sequence encoding metallocarboxypeptidase inhibitor protein |
| 09/03/1991 | US5045455 DNA sequences, genetic engineering, blood coagulants, hemophilia |
| 09/03/1991 | US5045203 Separation of protein antigens of Bordetella bacteria by affinity chromatography |
| 09/03/1991 | US5045201 Glass microbeads for biochemical separation of material from a fluid medium |
| 09/03/1991 | CA2077446A1 Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same |
| 09/03/1991 | CA2077352A1 Immunogenic compositions |
| 09/03/1991 | CA2077348A1 Antibody constructs with enhanced binding affinity |
| 09/03/1991 | CA2077345A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 09/03/1991 | CA2077338A1 Hybrid compound purification |
| 09/03/1991 | CA2037440A1 Her3: a novel egf receptor homolog |
| 09/03/1991 | CA2025695A1 Chimeric antibody against drug-resistant cancers and process for production thereof |
| 09/03/1991 | CA1288547C 1-(3-mercapto-2-methylpropanoyl) prolyl amino acid derivatives and salts thereof, processes for their preparation and pharmaceutical compositions containing such compounds |
| 09/01/1991 | CA2011253A1 Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 08/29/1991 | WO1991013359A1 A method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function |
| 08/29/1991 | WO1991013160A1 Mammalian expression vectors |
| 08/29/1991 | WO1991013081A1 Physiologically active substance well capable of permeating biomembrane |
| 08/29/1991 | DE4104308A1 Therapeutische verwendung von somatostatinpeptiden Therapeutic use of somatostatinpeptiden |
| 08/29/1991 | DE4006269A1 Antibody which binds to tumour necrosis factor receptors |